Search

everythinglearnresearchcommunity

for

Search:↓

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Dutasteride is more effective than finasteride for hair loss treatment.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Finasteride temporarily lowers male rat fertility without affecting libido.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Father's finasteride use may affect son's fertility and testicular function.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.